- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05843318
Water Intake and Weight Control in Older Adults
December 1, 2023 updated by: Brenda Davy, Virginia Polytechnic Institute and State University
This study is a randomized controlled intervention trial in adults aged 50+ years with overweight or obesity, which will compare three groups with different diet prescriptions: 1) pre-meal water consumption (500 ml, before each main meal) with a hypocaloric diet; 2) 1500 ml water consumed throughout the day with a hypocaloric diet; 3) hypocaloric diet with no instructions regarding water consumption.
Smart water bottles will objectively assess water intake timing and volume.
Urine osmolality, urine volume, and serum osmolality will be used as objective indicators of compliance with the water intake prescription.
We will investigate changes in perceived hunger and fullness and appetite-regulating hormones as potential mechanisms by which premeal water could improve appetite regulation.
We will also investigate the impact of water consumption and hydration on executive function capabilities, which may influence intervention adherence.
Although increasing water intake could be an effective weight management strategy, no evidence-based recommendations exist for the timing of water intake needed for this benefit.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
375
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brenda Davy, PhD RDN
- Phone Number: 540-231-6784
- Email: bdavy@vt.edu
Study Contact Backup
- Name: Elaina Marinik, PhD
- Phone Number: 540-231-0923
- Email: emarinik@vt.edu
Study Locations
-
-
Virginia
-
Blacksburg, Virginia, United States, 24061
- Recruiting
- Virginia Tech
-
Contact:
- Brenda M Davy, PhD
- Phone Number: 540-231-6784
- Email: bdavy@vt.edu
-
Contact:
- Elaina L Marinik, PhD
- Email: emarinik@vt.edu
-
Principal Investigator:
- Brenda M Davy, PhD, RD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- aged 50+ years
- BMI 25-40
- weight stable (+/- 2 kg) in past 6 months
- willing to provide consent and comply with study protocol
Exclusion Criteria:
- usual plain drinking water intake >1500 ml/d
- uncontrolled hypertension (>159/99 mmHg)
- medical condition requiring specialized diet prescription (eg, T2D, CHF wih fluid restriction)
- medical condition that precludes participating in a physical activity program (eg, orthopedic injury)
- current or history of GI disease (eg, Crohn's), GI surgery, or medications which impact GI function
- allergies or aversions to foods included in the test meals
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pre-meal water + Hypocaloric diet
premeal water ( 500 ml) before each main meal, three times per day + hypocaloric diet
|
Individuals will be randomly assigned to one of three groups.
All individuals will receive counseling in a structured hypocaloric meal plan (1200-1500 kcal) that is consistent with a healthy dietary pattern as described by the Dietary Guidelines for Americans.
This group will receive specific instructions for daily water intake timing and volume.
|
Experimental: Daily water + Hypocaloric diet
total daily water prescription (1500 ml/d) + hypocaloric diet
|
Individuals will be randomly assigned to one of three groups.
All individuals will receive counseling in a structured hypocaloric meal plan (1200-1500 kcal) that is consistent with a healthy dietary pattern as described by the Dietary Guidelines for Americans.
This group will receive specific instructions for total daily water intake.
|
Active Comparator: Hypocaloric Diet alone
hypocaloric diet with not instructions regarding water intake
|
Individuals will be randomly assigned to one of three groups.
All individuals will receive counseling in a structured hypocaloric meal plan (1200-1500 kcal) that is consistent with a healthy dietary pattern as described by the Dietary Guidelines for Americans.
This group will receive instructions in the hypocaloric diet, without specific fluid intake recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight change
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Body weight change in weight loss and weight loss maintenance phases
|
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in appetite sensations
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Changes in hunger and fullness, assessed using 100mm Visual Analog Scales (VAS), in weight loss and weight loss maintenance phases.
These changes may mediate adherence to the hypocaloric diet and weight loss outcomes.
|
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Change in hydration status
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Changes in hydration status, assessed using urine and serum osmolality, urine specific gravity, and serum sodium, in weight loss and weight loss maintenance phases.
These changes may mediate intervention adherence.
|
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Change in executive function (EF)
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Changes in EF (attention, inhibition) assessed using ePRIME computerized tasks, in weight loss and weight loss maintenance phases.
These changes may mediate intervention adherence.
|
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in appetite hormones
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Changes in appetite hormones, specifically blood concentrations of ghrelin, PYY 3-36, leptin, and CCK in response to a standardized test meal with an energy content of 25% estimated energy requirements.
|
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Brenda Davy, PhD RDN, Virginia Polytechnic Institute and State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 13, 2023
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
March 31, 2028
Study Registration Dates
First Submitted
April 12, 2023
First Submitted That Met QC Criteria
April 24, 2023
First Posted (Actual)
May 6, 2023
Study Record Updates
Last Update Posted (Actual)
December 5, 2023
Last Update Submitted That Met QC Criteria
December 1, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-624
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted